Amarin Corp Plc (AMRN)

[zumantu]

Everyonesguess, more reps are need to help Docs shift their patients from now approval withdrawn Fibrates that represent 300K a week. Remember current sales force is focused on high writers of Omega 3's Now it's even easier moving Docs from disapproved Fibrates to Vascepa.

Huge opportunity with considering R-I outcomes